YuanMing Capital
13
79M
8
1.44
3
0.38
2
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Haidian. The fund was located in Asia if to be more exact in China.
Among the various public portfolio startups of the fund, we may underline Ansun BioPharma, JW Therapeutics, CANbridge Life Sciences Among the most successful fund investment fields, there are Music, Health Care. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the YuanMing Capital, startups are often financed by Venrock, CHL Medical Partners, ProQuest Investments. The meaningful sponsors for the fund in investment in the same round are Oriza Seed Capital (Oriza Yuandian), WuXi AppTec, Matrix Partners China. In the next rounds fund is usually obtained by State Development & Investment Corporation (SDIC), RMB Funds, Qiming Venture Partners.
The fund was created by Fiona Gong, Lawrence Tian, Ming Jiang, Tina Yu. We also calculated 3 valuable employees in our database.
The high activity for fund was in 2018. The top amount of exits for fund were in 2010. This YuanMing Capital works on 19 percentage points less the average amount of lead investments comparing to the other organizations. The average startup value when the investment from YuanMing Capital is 100-500 millions dollars. The usual things for fund are deals in the range of 50 - 100 millions dollars. The real fund results show that this VC is 20 percentage points more often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 13
- Lead investments
- 3
- Exits
- 2
- Rounds per year
- 1.44
- Follow on index
- 0.38
- Investments by industry
- Biotechnology (10)
- Health Care (8)
- Pharmaceutical (6)
- Biopharma (4)
- Medical (4) Show 7 more
- Investments by region
-
- China (8)
- United States (3)
- United Kingdom (2)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 112M
- Group Appearance index
- 1.00
- Avg. company exit year
- 21
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ansun BioPharma | 14 May 2018 | Biotechnology, Health Care, Medical, Biopharma, Clinical Trials | Early Stage Venture | 85M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.